PRGO
Price
$22.51
Change
+$0.36 (+1.63%)
Updated
Oct 3 closing price
Capitalization
3.1B
31 days until earnings call
ZTS
Price
$146.42
Change
-$0.07 (-0.05%)
Updated
Oct 3 closing price
Capitalization
64.89B
30 days until earnings call
Interact to see
Advertisement

PRGO vs ZTS

Header iconPRGO vs ZTS Comparison
Open Charts PRGO vs ZTSBanner chart's image
Perrigo
Price$22.51
Change+$0.36 (+1.63%)
Volume$1.6M
Capitalization3.1B
ZOETIS
Price$146.42
Change-$0.07 (-0.05%)
Volume$2.57M
Capitalization64.89B
PRGO vs ZTS Comparison Chart in %
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRGO vs. ZTS commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGO is a Buy and ZTS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (PRGO: $22.51 vs. ZTS: $146.42)
Brand notoriety: PRGO: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRGO: 83% vs. ZTS: 87%
Market capitalization -- PRGO: $3.1B vs. ZTS: $64.89B
PRGO [@Pharmaceuticals: Generic] is valued at $3.1B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $64.89B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.89B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRGO’s FA Score shows that 2 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • PRGO’s FA Score: 2 green, 3 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRGO’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • PRGO’s TA Score: 5 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ZTS.

Price Growth

PRGO (@Pharmaceuticals: Generic) experienced а +4.94% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

Reported Earning Dates

PRGO is expected to report earnings on Nov 05, 2025.

ZTS is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($64.9B) has a higher market cap than PRGO($3.1B). PRGO has higher P/E ratio than ZTS: PRGO (2818.00) vs ZTS (25.21). ZTS (-9.255) and PRGO (-9.492) have similar YTD gains . ZTS has higher annual earnings (EBITDA): 4.02B vs. PRGO (612M). ZTS has more cash in the bank: 1.44B vs. PRGO (454M). PRGO has less debt than ZTS: PRGO (3.65B) vs ZTS (6.79B). ZTS has higher revenues than PRGO: ZTS (9.39B) vs PRGO (4.33B).
PRGOZTSPRGO / ZTS
Capitalization3.1B64.9B5%
EBITDA612M4.02B15%
Gain YTD-9.492-9.255103%
P/E Ratio2818.0025.2111,177%
Revenue4.33B9.39B46%
Total Cash454M1.44B32%
Total Debt3.65B6.79B54%
FUNDAMENTALS RATINGS
PRGO vs ZTS: Fundamental Ratings
PRGO
ZTS
OUTLOOK RATING
1..100
762
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9219
PRICE GROWTH RATING
1..100
8063
P/E GROWTH RATING
1..100
284
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is in the same range as ZTS (34) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew similarly to ZTS’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is significantly better than the same rating for PRGO (92) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew significantly faster than PRGO’s over the last 12 months.

ZTS's Price Growth Rating (63) in the Pharmaceuticals Generic industry is in the same range as PRGO (80) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for ZTS (84) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew significantly faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRGOZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 5 days ago
57%
Declines
ODDS (%)
Bearish Trend 14 days ago
65%
Bearish Trend 3 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDMAX141.771.04
+0.74%
Janus Henderson Enterprise A
PGIIX28.250.12
+0.43%
Polen Global Growth Institutional
DMAGX19.130.07
+0.37%
Driehaus Global Fund
PAXLX14.450.04
+0.28%
Impax Large Cap Fund Individual Investor
GAOCX21.770.05
+0.23%
JPMorgan Global Allocation C

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.05%
ELAN - ZTS
48%
Loosely correlated
+0.83%
VTRS - ZTS
48%
Loosely correlated
+0.79%
PAHC - ZTS
42%
Loosely correlated
-1.77%
HLN - ZTS
39%
Loosely correlated
+0.79%
AMRX - ZTS
38%
Loosely correlated
-0.10%
More